These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33213541)

  • 1. Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial.
    Ang YS; Bruder GE; Keilp JG; Rutherford A; Alschuler DM; Pechtel P; Webb CA; Carmody T; Fava M; Cusin C; McGrath PJ; Weissman M; Parsey R; Oquendo MA; McInnis MG; Cooper CM; Deldin P; Trivedi MH; Pizzagalli DA
    Psychol Med; 2022 Oct; 52(13):2441-2449. PubMed ID: 33213541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.
    Trivedi MH; McGrath PJ; Fava M; Parsey RV; Kurian BT; Phillips ML; Oquendo MA; Bruder G; Pizzagalli D; Toups M; Cooper C; Adams P; Weyandt S; Morris DW; Grannemann BD; Ogden RT; Buckner R; McInnis M; Kraemer HC; Petkova E; Carmody TJ; Weissman MM
    J Psychiatr Res; 2016 Jul; 78():11-23. PubMed ID: 27038550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical Trial.
    Nguyen KP; Chin Fatt C; Treacher A; Mellema C; Cooper C; Jha MK; Kurian B; Fava M; McGrath PJ; Weissman M; Phillips ML; Trivedi MH; Montillo AA
    Biol Psychiatry; 2022 Mar; 91(6):550-560. PubMed ID: 34916068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse.
    Ang YS; Kaiser R; Deckersbach T; Almeida J; Phillips ML; Chase HW; Webb CA; Parsey R; Fava M; McGrath P; Weissman M; Adams P; Deldin P; Oquendo MA; McInnis MG; Carmody T; Bruder G; Cooper CM; Chin Fatt CR; Trivedi MH; Pizzagalli DA
    Biol Psychiatry; 2020 Oct; 88(8):657-667. PubMed ID: 32507389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals.
    Greenberg T; Fournier JC; Stiffler R; Chase HW; Almeida JR; Aslam H; Deckersbach T; Cooper C; Toups MS; Carmody T; Kurian B; Peltier S; Adams P; McInnis MG; Oquendo MA; Fava M; Parsey R; McGrath PJ; Weissman M; Trivedi M; Phillips ML
    Mol Psychiatry; 2020 Jul; 25(7):1526-1536. PubMed ID: 31462766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial.
    Pizzagalli DA; Webb CA; Dillon DG; Tenke CE; Kayser J; Goer F; Fava M; McGrath P; Weissman M; Parsey R; Adams P; Trombello J; Cooper C; Deldin P; Oquendo MA; McInnis MG; Carmody T; Bruder G; Trivedi MH
    JAMA Psychiatry; 2018 Jun; 75(6):547-554. PubMed ID: 29641834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.
    Croft H; Settle E; Houser T; Batey SR; Donahue RM; Ascher JA
    Clin Ther; 1999 Apr; 21(4):643-58. PubMed ID: 10363731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does pretreatment anxiety predict response to either bupropion SR or sertraline?
    Rush AJ; Batey SR; Donahue RM; Ascher JA; Carmody TJ; Metz A
    J Affect Disord; 2001 Apr; 64(1):81-7. PubMed ID: 11292522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study.
    Webb CA; Trivedi MH; Cohen ZD; Dillon DG; Fournier JC; Goer F; Fava M; McGrath PJ; Weissman M; Parsey R; Adams P; Trombello JM; Cooper C; Deldin P; Oquendo MA; McInnis MG; Huys Q; Bruder G; Kurian BT; Jha M; DeRubeis RJ; Pizzagalli DA
    Psychol Med; 2019 May; 49(7):1118-1127. PubMed ID: 29962359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?
    Trivedi MH; Rush AJ; Carmody TJ; Donahue RM; Bolden-Watson C; Houser TL; Metz A
    J Clin Psychiatry; 2001 Oct; 62(10):776-81. PubMed ID: 11816866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated Brain Aging in Adults With Major Depressive Disorder Predicts Poorer Outcome With Sertraline: Findings From the EMBARC Study.
    Jha MK; Chin Fatt C; Minhajuddin A; Mayes TL; Trivedi MH
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Apr; 8(4):462-470. PubMed ID: 36179972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvements in irritability with sertraline versus placebo: Findings from the EMBARC study.
    Jha MK; Minhajuddin A; Chin Fatt C; Trivedi MH
    J Affect Disord; 2020 Oct; 275():44-47. PubMed ID: 32658822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder: Secondary Analysis of a Randomized Clinical Trial.
    Rolle CE; Fonzo GA; Wu W; Toll R; Jha MK; Cooper C; Chin-Fatt C; Pizzagalli DA; Trombello JM; Deckersbach T; Fava M; Weissman MM; Trivedi MH; Etkin A
    JAMA Psychiatry; 2020 Apr; 77(4):397-408. PubMed ID: 31895437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
    Hedayati SS; Gregg LP; Carmody T; Jain N; Toups M; Rush AJ; Toto RD; Trivedi MH
    JAMA; 2017 Nov; 318(19):1876-1890. PubMed ID: 29101402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
    Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B
    Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dorsolateral Prefrontal Cortex and Subcallosal Cingulate Connectivity Show Preferential Antidepressant Response in Major Depressive Disorder.
    Chin Fatt CR; Cooper C; Jha MK; Aslan S; Grannemann B; Kurian B; Greer TL; Fava M; Weissman M; McGrath PJ; Parsey RV; Etkin A; Phillips ML; Trivedi MH
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):20-28. PubMed ID: 32921587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression.
    Chin Fatt CR; Jha MK; Cooper CM; Fonzo G; South C; Grannemann B; Carmody T; Greer TL; Kurian B; Fava M; McGrath PJ; Adams P; McInnis M; Parsey RV; Weissman M; Phillips ML; Etkin A; Trivedi MH
    Am J Psychiatry; 2020 Feb; 177(2):143-154. PubMed ID: 31537090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients.
    Trombello JM; Killian MO; Grannemann BD; Rush AJ; Mayes TL; Parsey RV; McInnis M; Jha MK; Ali A; McGrath PJ; Adams P; Oquendo MA; Weissman MM; Carmody TJ; Trivedi MH
    J Psychopharmacol; 2019 Feb; 33(2):185-193. PubMed ID: 30652941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.
    Kaddurah-Daouk R; Boyle SH; Matson W; Sharma S; Matson S; Zhu H; Bogdanov MB; Churchill E; Krishnan RR; Rush AJ; Pickering E; Delnomdedieu M
    Transl Psychiatry; 2011; 1(7):e26-. PubMed ID: 22162828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
    Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
    Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.